As the Omicron COVID-19 variant which is now the most dominant strain in the world rapidly spread in Korea SK Bioscience also started developing ...
News
- SK Bioscience to develop COVID-19 Omicron-specific vaccine - Big News Network.com
- 'Very over sold': Biotech brags about PhII Alzheimer's data, but experts are underwhelmed ...
Alzheon, a little biotech developing an oral amyloid-clearing tablet, ... the neurobiology chair at the University of Texas at San Antonio, ...
- 1819 Innovation Hub tenant inks key partnership with Korea VC firm - The Business Journals
A biotech firm that moved its headquarters from New York to Cincinnati in late 2021 has announced its first major collaboration since planting ...
- UTSA receives $6.8 million in NIH funding to establish research center targeting valley fever
Mycology and immunology researchers from The University of Texas at San Antonio have been selected to receive a five-year, $6.8 million grant from ...
- Initial COVID-19 infection on the single-cell level, revealed - Newswise
Source Newsroom: Texas Biomedical Research Institute ... Newswise — SAN ANTONIO (February 8, 2022) – What is going on at the single-cell level in ...